Serum lipids and hippocampal volume: The link to Alzheimer's disease?

@article{Wolf2004SerumLA,
  title={Serum lipids and hippocampal volume: The link to Alzheimer's disease?},
  author={Henrike Wolf and Anke Hensel and Thomas Arendt and Miia Kivipelto and Bengt Winblad and H. -J. Gertz},
  journal={Annals of Neurology},
  year={2004},
  volume={56}
}
The association between hippocampal volume (as a presumed index of Alzheimer's disease pathology) with serum total cholesterol, high‐density lipoprotein cholesterol, and low‐density lipoprotein cholesterol was studied in 86 elderly subjects with a range of cognitive functions. High‐density lipoprotein cholesterol, but not low‐density lipoprotein cholesterol or total cholesterol, was associated with hippocampal volume and dementia. This is compatible with protective effects of high‐density… 
Relationship between cholesterol metabolism, ApoE and brain volumes in Alzheimer's disease
TLDR
Significant correlations were found between cholesterol precursors lathosterol, lanosterol and 24S-hydroxycholesterol (a putative marker of brain cholesterol turnover) in plasma and brain atrophy as quantified by MRI.
Plasma Lipids as Biomarkers for Alzheimer's Disease: A Systematic Review
TLDR
An association between plasma lipids, polymorphisms in genes associated with cholesterol transport, and Alzheimer's disease is found, proving that plasmalipids can be used as biomarkers for early diagnosis of Alzheimer’s disease.
Association of cardiovascular factors and Alzheimer's disease plasma amyloid-beta protein in subjective memory complainers.
TLDR
A novel negative association between HDL and Abeta is reported, which if demonstrated to be causal has implications for the development of lifestyle interventions and/or novel therapeutics.
Low-Density Lipoprotein Cholesterol and Alzheimer's Disease: A Systematic Review and Meta-Analysis
TLDR
Elevated concentration of LDL-c (>121 mg/dl) may be a potential risk factor for AD, and this association is strong in patients aged 60–70 years, but vanishes with advancing age.
High‐density lipoprotein‐related cholesterol metabolism in Alzheimer’s disease
TLDR
The pathway that leads to HDL formation and its subsequent remodelling and catabolism is discussed with regards to the possible involvement of HDL ‘protein cargo’ in Alzheimer's disease.
Elevated HDL Levels Linked to Poorer Cognitive Ability in Females With Parkinson’s Disease
TLDR
Higher serum HDL associates with poorer cognitive function in females with PD and presents a sex-specific biomarker for cognitive impairment in PD.
Cholesterol and Late-Life Cognitive Decline
TLDR
Factors that influence cholesterol metabolism, such as dietary intake, are shown to play a role in late-life cognitive function and the risk of dementia, but the association is strongly age-dependent.
Circulating biomarkers of cognitive decline and dementia.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 19 REFERENCES
Association between high‐density lipoprotein and cognitive impairment in the oldest old
TLDR
At least part of the association between high‐density lipoprotein cholesterol and cognitive function is independent of atherosclerotic disease, and this association is associated with cognitive impairment and dementia.
Relationships between Cholesterol, Apolipoprotein E Polymorphism and Dementia: A Cross-Sectional Analysis from the PAQUID Study
TLDR
Elevated high-density lipoprotein cholesterol was associated with a significantly decreased risk of dementia, independent of apoE status and other potential confounding variables, suggesting that cholesterol fractions could be involved in both Alzheimer’s disease and vascular dementia.
Differences in the Aβ40/Aβ42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype
TLDR
CSF LPs from healthy, cognitively normal, fasted, elderly individuals at different risk for AD based on ApoE genotype were characterized and plasma and CSF high‐density lipoprotein (HDL) cholesterol and apolipoprotein AI (ApoAI) levels were correlated.
Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype.
TLDR
CSF LPs from healthy, cognitively normal, fasted, elderly individuals at different risk for AD based on ApoE genotype were characterized and plasma and CSF high-density lipoprotein (HDL) cholesterol and apolipoprotein AI (ApoAI) levels were correlated.
The effect of APOE on dementia is not through atherosclerosis: the Rotterdam Study.
TLDR
This study suggests that atherosclerosis is not an intermediate factor in the association of APOE with dementia, as neither adjusting nor stratification for Atherosclerosis altered the association.
Homocysteine and brain atrophy on MRI of non-demented elderly.
TLDR
The hypothesis that higher plasma homocysteine levels are associated with more atrophy of the hippocampus and cortical regions in elderly at risk of Alzheimer's disease is supported.
Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study.
TLDR
Raised systolic blood pressure and high serum cholesterol concentration, and in particular the combination of these risks, in midlife increase the risk of Alzheimer's disease in later life.
Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model
TLDR
It is proposed that diet can be used to modulate the risk of developing AD and high dietary cholesterol increases Aβ accumulation and accelerates the AD-related pathology observed in this animal model.
...
1
2
...